CatalystFDA/Bio

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

FDA approval enables commercial release of Ryoncil, a direct revenue catalyst for Mesoblast.

What changed

FDA approval enables commercial release of Ryoncil, a direct revenue catalyst for Mesoblast.

Why it matters

FDA approval enables commercial release of Ryoncil, a direct revenue catalyst for Mesoblast. — impact context not separately stored; see What changed.

Sources

eodhd